December 04, 2025

Universität Heidelberg: Outstanding Placings in Shanghai Ranking of Academic Subjects

Universität Heidelberg: Outstanding Placings in Shanghai Ranking of Academic Subjects

Clinical medicine and medical technology internationally in 18th position – top placements for biological sciences and human biological sciences

With clinical medicine and medical technology, Heidelberg University is among the best representatives of the medical sciences worldwide. In the 2025 Global Ranking of Academic Subjects, both rank 18th internationally. Clinical medicine thus continues to hold the top position in Germany, while medical technology takes third place. The biological sciences are once again at the top of the list in Germany, ranking 39th worldwide.

Human biological sciences in Heidelberg are also among the “top 50” in the world in their subject area. Like the biological sciences, they are classed in the field of life sciences and, after jumping from the 51 to 75 ranking group, now rank 44th internationally, which means third place in Germany. The “top 100” subjects in the natural sciences include physics at Heidelberg University, which has moved up from the 76 to 100 ranking group to the 51 to 75 ranking group and now takes second place nationally.

The ranking of subjects appeared in November 2025 and is part of the Academic Ranking of World Universities, also called the Shanghai Ranking. The subjects are grouped into five academic fields and evaluated according to nine indicators. These include mainly publication data and the prizes and awards won at a university, as well as the number of most-cited researchers or editors in international journals, among other things. The individual indicators are applied in five different categories and are weighted differently depending on the subject.

In the overall Shanghai Ranking published in August this year, Heidelberg University took third place in Germany, ranking 16th in Europe and 51st internationally.

Further information

Our latest News

discover more
RHEACELL makes second location in Heidelberg visible

RHEACELL makes second location in Heidelberg visible

Heidelberg, January 28, 2026 – RHEACELL GmbH & Co. KG is continuing to expand its presence in Heidelberg and moved into a second location in the Pfaffengrund district in August last year. At the start of the year, the location is now also becoming visible to the outside world: this week, the company logo will […]

TUM Researchers receive two ERC Grants

TUM Researchers receive two ERC Grants

The European Research Council’s (ERC) Proof of Concept Grants are designed to help researchers turn their findings into real‑world innovations. Two ERC‑funded follow‑up projects at TUM will each receive approximately 150,000 euros in support. The projects focus on virus‑driven cancer treatments and new ways to supply electrons for enzyme‑based technologies. Researchers at TUM have secured […]

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Weight Loss in Cancer: Organs Respond to the Disease in a Coordinated Way

Cachexia is a metabolic disorder that causes uncontrolled weight loss and muscle wasting in chronic diseases and cancer. A new study by Helmholtz Munich, in collaboration with the Institute of Physiology of the Czech Academy of Sciences in Prague, Heidelberg University Hospital, the German Center for Diabetes Research (DZD), and the German Center for Cardiovascular […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp